Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation
暂无分享,去创建一个
R Engers | W. Schulz | R. Ackermann | C. Steinhoff | H. Seifert | M. Müller | R. Engers | M Müller | A. Florl | C. Hader | W A Schulz | A R Florl | C Steinhoff | H-H Seifert | C Hader | R Ackermann | Mirko Müller | Wolfgang A. Schulz | Rolf Ackermann | Rainer Engers
[1] J. Issa,et al. CpG-island methylation in aging and cancer. , 2000, Current topics in microbiology and immunology.
[2] T. Visakorpi,et al. Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma , 2002, Genes, chromosomes & cancer.
[3] M. Ehrlich,et al. DNA methylation in cancer: too much, but also too little , 2002, Oncogene.
[4] A. D. De Marzo,et al. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer , 2004, Journal of cellular biochemistry.
[5] W. Schulz,et al. High frequency of alterations in DNA methylation in adenocarcinoma of the prostate , 1999, The Prostate.
[6] R. Hayes,et al. Hypermethylation of GSTP1, CD44, and E‐cadherin genes in prostate cancer among US Blacks and Whites , 2003, The Prostate.
[7] J. Herman,et al. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer , 1997, Genes, chromosomes & cancer.
[8] T. Guthrie,et al. Prostate cancer. , 2020, American family physician.
[9] Keith D Robertson,et al. DNA methylation, methyltransferases, and cancer , 2001, Oncogene.
[10] John D Minna,et al. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] J. Herman,et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. , 1995, Cancer research.
[12] P. V. van Helden,et al. Hypomethylation of DNA in pathological conditions of the human prostate. , 1987, Cancer research.
[13] J. Herman,et al. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. , 1998, Cancer research.
[14] J. Brooks,et al. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[15] S. Clark,et al. Detailed methylation analysis of the glutathione S-transferase π (GSTP1) gene in prostate cancer , 1999, Oncogene.
[16] W. Schulz,et al. DNA Methylation in Urological Cancers , 2005 .
[17] Issa Jp. CpG-island methylation in aging and cancer. , 2000 .
[18] N. Ahuja,et al. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[19] G. Pfeifer,et al. Frequent hypermethylation of the RASSF1A gene in prostate cancer , 2002, Oncogene.
[20] Masatoshi Watanabe,et al. The Role of Epigenetic Modifications in Retinoic Acid Receptor β2 Gene Expression in Human Prostate Cancers , 2001, Laboratory Investigation.
[21] K. Miller,et al. DNA-based detection of prostate cancer in urine after prostatic massage. , 2001, Urology.
[22] Matty P. Weijenberg,et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer , 2002, Nature Genetics.
[23] Jin-Tang Dong. Chromosomal Deletions and Tumor Suppressor Genes in Prostate Cancer , 2004, Cancer and Metastasis Reviews.
[24] J. Herman,et al. Methylation Patterns of the E-cadherin 5′ CpG Island Are Unstable and Reflect the Dynamic, Heterogeneous Loss of E-cadherin Expression during Metastatic Progression* , 2000, The Journal of Biological Chemistry.
[25] S. Warren,et al. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. , 2000, Cancer research.
[26] J. Hicks,et al. Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. , 2003, The American journal of pathology.
[27] D. Sidransky,et al. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. , 2001, Journal of the National Cancer Institute.
[28] Hiroyuki Takahashi,et al. Altered methylation of multiple genes in carcinogenesis of the prostate , 2003, International journal of cancer.
[29] R. Löwer,et al. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas , 1999, British Journal of Cancer.
[30] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[31] R. Jaenisch,et al. Chromosomal Instability and Tumors Promoted by DNA Hypomethylation , 2003, Science.
[32] W. Isaacs,et al. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[33] P. Laird,et al. Hypomethylation and hypermethylation of DNA in Wilms tumors , 2002, Oncogene.
[34] T. Ishikawa,et al. Photoprotective role of epidermal melanin granules against ultraviolet damage and DNA repair in guinea pig skin. , 1984, Cancer research.
[35] J. Brooks,et al. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.